Decision guides for investors who need the structure, not the hype.
AltStreet guides are built to answer the real implementation questions: how access works, what you are actually buying, where fees hide, and which path makes sense once transfer risk and liquidity timing are included.
Executive Take
Institutional-grade analysis for complex alternative assets.
These guides are written to help readers evaluate access, structure, liquidity, fees, and implementation risk with the level of clarity expected in serious alternative investment research.
Top Pick for Intent
StartEngine vs EquityZen
A practical comparison of two pre-IPO access models: EquityZen's agency-intermediated SPVs and StartEngine's principal-traded Reg D Series. Covers fee transparency, wedge math, regulatory surface, audit posture, K-1 timing, and liquidity reality.
Featured Guide
StartEngine vs EquityZen
Principal-trading wedges, agency fees, and conflict surfaces mapped side by side.
Core Lens
Net Price
We compare structures, not just headline fees or platform branding.
Primary Risk
ROFR
The transfer can still fail after time, paperwork, and mental capital are committed.
Institutional Analysis
Institutional-grade alternative investment guides
AltStreet guides are built for investors who need more than a headline summary. Each guide is designed to surface structure, fee drag, liquidity constraints, tax considerations, and implementation risk in a format that reflects how institutional capital actually underwrites alternative assets.
1. Structure before story
We focus first on what the investor is actually buying: direct shares, SPV interests, fund exposure, or structured vehicles. That framing matters more than platform branding or promotional language.
2. Execution risk made explicit
Alternative investments often fail in the gap between thesis and execution. We highlight transfer restrictions, lockups, fee layers, tax timing, and liquidity reality so those risks are visible before capital is committed.
3. Comparison-ready research
The goal is practical decision support. These guides are built to help readers compare pathways, evaluate tradeoffs, and identify where institutional discipline leads to a different conclusion than surface-level marketing.
Current Coverage
Featured Guides
Built for investors making real decisions around access, structure, and execution.
Pre-IPO Investing
How to Buy OpenAI Stock Pre-IPO
A decision guide to OpenAI secondary-market access, including Forge, Hiive, EquityZen, SPV mechanics, transfer approval risk, cash burn dynamics, and retail alternatives.
Market Take
Best guide for understanding OpenAI transfer restrictions before chasing secondary access.
How to Buy Databricks Stock Pre-IPO
A decision guide to Databricks secondary-market access, including SPV-only structure, Forge and Hiive pricing, EquityZen access, IPO timing, and valuation risk.
Market Take
Best guide for understanding Databricks SPV-only access and near-term IPO pricing risk.
How to Buy Tenstorrent Stock Pre-IPO
A decision guide to Tenstorrent secondary access: the September 2026 Form D reporting $1.29 billion sold, the twelve SPV series that have filed their own notices, Hiive's $50,000 minimums, and the registered-fund marks that disagree by 47.6 percent on the same share class.
Market Take
Best guide for understanding Tenstorrent SPV-only access and why no reference price exists.
How to Buy Stripe Stock Pre-IPO
A decision guide to Stripe secondary-market access, tender offers, ROFR mechanics, platform pricing, retail alternatives, and why profitability reduces IPO urgency.
Market Take
Best guide for understanding Stripe tender offers, secondary pricing, and uncertain IPO timing.
How to Buy Anthropic Stock Pre-IPO
A decision guide to Anthropic secondary-market access, including the void-transfer warning, SPV prohibition, board authorization requirements, VCX exposure, and retail alternatives.
Market Take
Best guide for understanding Anthropic's void-transfer warning and authorized access constraints.
How to Buy Anduril Stock Pre-IPO
A decision guide to Anduril secondary-market access, including the $61 billion Series H, defense-sector transfer scrutiny, thin secondary supply, Arsenal-1 manufacturing risk, and IPO timing.
Market Take
Best guide for understanding defense-sector transfer scrutiny and Anduril's profitability-before-IPO path.
How to Buy ByteDance Stock Pre-IPO
A decision guide to ByteDance secondary access, built on the per-share marks BlackRock, T. Rowe Price and Fidelity file with the SEC every quarter. The company buys shares back from its own employees at a widening discount to those marks, two separate transfer regimes govern who may sell, and six listed funds already hold ByteDance at a discount to net asset value.
Market Take
Best guide for the gap between what ByteDance pays insiders and what its institutional holders mark it at, and for the listed funds that offer the exposure without accreditation.
How to Buy Neuralink Stock Pre-IPO
A decision guide to Neuralink secondary access, built on all six Form D filings read from EDGAR. Two SEC-registered funds that own the Series E carry it at $50.50 and $69.49 a share while secondary platforms quote $156 to $295, there is no IPO statement from the company in either direction, and no implanted brain-computer interface has any FDA marketing authorization.
Market Take
Best guide for reconciling the fourfold gap between what Neuralink's owners mark it at and what its sellers quote, and for the one route open to non-accredited investors.
Platform Comparisons
StartEngine vs EquityZen
A focused pre-IPO platform comparison of StartEngine's principal-trading Reg D Series model against EquityZen's agency-intermediated SPV access, including fees, conflicts, regulation, K-1 timing, and liquidity.
Market Take
Best guide for comparing principal-traded pre-IPO Series with agency-intermediated secondary SPVs.
StartEngine vs Clarity (formerly Hiive)
A focused pre-IPO platform comparison of StartEngine's principal-traded Reg D Series model against Hiive's live order-book marketplace, including pricing, ROFR, fund administration, tax reporting, and liquidity.
Market Take
Best guide for comparing marked-up Series access with live order-book pre-IPO execution.
StartEngine vs Wefunder
A focused Reg CF platform comparison of StartEngine and Wefunder across funding-portal mechanics, fees, SPV side-cars, FINRA history, issuer outcomes, secondary liquidity, and investor fit.
Market Take
Best guide for choosing between two large US equity-crowdfunding platforms.
EquityZen vs Forge vs Clarity (formerly Hiive)
A side-by-side comparison of the three major pre-IPO secondary platforms, including fees, minimums, ROFR handling, price discovery, fund structures, and investor fit.
Market Take
Best guide for choosing between the major pre-IPO platform models.
Equitybee vs EquityZen
A focused pre-IPO platform comparison of Equitybee's option-exercise funding claims against EquityZen's SPV-backed secondary share access, including ownership, fees, upside, governance, taxes, and liquidity.
Market Take
Best guide for deciding between option-exercise financing exposure and secondary SPV share exposure.
Equitybee vs Forge Global
A focused pre-IPO platform comparison of Equitybee's option-exercise funding claims against Forge Global's secondary marketplace, fund SPVs, data layer, and custody infrastructure.
Market Take
Best guide for deciding between option-exercise financing exposure and Forge's share-backed marketplace and fund routes.
EquityZen vs UpMarket
A focused pre-IPO platform comparison of EquityZen's single-layer SPV structure against UpMarket's fee-layered feeder fund model, including fees, access, regulation, and liquidity.
Market Take
Best guide for comparing a single-layer pre-IPO SPV with a layered feeder-fund access model.
Alt vs Courtyard
Two vaults for graded cards compared: Courtyard's NFT ownership record, fee-free marketplace, packs at 96 percent of its own expected value and a buyback with a 6 percent fee, against Alt's open intake, 4 to 14 percent seller fees, a 20 percent auction premium shared with the seller, outtake fees on Alt Value, cash advances and loans at SOFR plus 9 to 10 percent.
Market Take
Best guide for deciding where to hold and sell a graded card when one vault records ownership on a public chain but takes no new cards, and the other takes cards and charges for every move on its own valuation.
Amber Farmland vs AcreTrader
Amber Farmland Investments (formerly Iroquois Valley Farmland REIT), a $10,000 farmland REIT open to non-accredited investors, against AcreTrader's $15,000 single-farm LLCs for accredited investors and its separate diversified fund: what you own, access, returns on matched dates against 84 realized exits, fees, redemption limits, tenant risk and tax forms.
Market Take
Best guide for deciding between a diversified farmland REIT with a capped redemption program and individual farms you choose and hold until the manager sells.
Amber Farmland vs Farmland LP
Amber Farmland Investments (formerly Iroquois Valley), a $10,000 organic farmland REIT leasing to independent farmers, against Farmland LP's $100,000 Fund I preferred for accredited investors: who farms the land, crops and water, the organic transition, how values and returns are calculated, fees, cash redemption versus conversion, and how each substantiates its impact claims.
Market Take
Best guide for choosing between a transparent, diversified organic farmland REIT and a concentrated preferred in one sponsor's two-farm fund whose fees and financials are not public.
Commonwealth Sports vs Finlete
Commonwealth's golf and tennis earnings shares against Finlete's 25-year baseball classes, from the SEC filings: what you legally own, which earnings count, term, caps and buy-downs, one dollar traced from the athlete to the investor, payback thresholds, and where the documents conflict.
Market Take
Best guide for judging an athlete earnings offering: which pay counts, how much of each dollar reaches you, and what must happen before anything is owed.
Supervest vs Groundfloor Notes
Merchant cash advance notes against real-estate-loan notes: issuer-level notes compared with issuer-level notes (Groundfloor's single-loan LROs kept separate), on collateral, interest timing, minimums, accreditation, what happens when repayment runs late, and each sponsor's finances, including Groundfloor's going-concern paragraph.
Market Take
Best guide for choosing between a higher stated rate on undisclosed security and a lower rate on a disclosed first-priority interest in real estate loans.
Supervest vs Yieldstreet (Willow Wealth)
Supervest's 12- to 36-month MCA notes against Willow Wealth's 3- to 9-month Short Term Notes: what secures each, Willow's 5% first-loss purchase, monthly interest, minimums, the shared extension footnote, and each program's record.
Market Take
Best guide for comparing two note programs on security and first-loss capital rather than on headline rate.
Supervest vs Percent
Two ways to lend into short-term credit as an accredited investor: Supervest's fixed-rate notes from a pooled merchant cash advance series against Percent's deal-by-deal notes, compared on the legal claim, MCA exposure, net coupon after fees, diversification, delinquency and loss disclosures, maturity extensions and the regulatory record.
Market Take
Best guide for weighing a higher no-fee fixed coupon against knowing what the note is backed by and how the platform's deals have performed.
Commonwealth vs Wasabi Ventures Stables vs MyRacehorse
Racehorse microshares against club membership, from the filings and Wasabi's member agreement: what you legally hold, where a $500 budget goes, reserves versus costs netted at settlement, Wasabi's racing, foal, weanling and yearling programs separated, overruns, fees and profit shares, reports and settlement.
Market Take
Best guide for comparing racehorse ownership costs: whether upkeep is reserved in the price, billed or netted at the end, and who funds an overrun.
Commonwealth vs MyRacehorse
The two retail racehorse platforms compared from their SEC filings: what a $50 share actually buys, front-end and back-end fees, illustrative sale-only recovery multiples, payouts on record, owner perks, exemptions by offering, exits and tax forms.
Market Take
Best guide for judging a specific racehorse offering: how much of the price buys the horse, what the manager takes at the sale, and which tax form arrives.
YLDS vs Franklin Benji (FOBXX)
Figure's YLDS, an SEC-registered unsecured debt certificate paying SOFR minus 0.35%, against Franklin Templeton's Benji, an on-chain government money market fund: what you own, who can buy, same-date yields, what stands behind the dollar, who holds them, redemption, fees and tax.
Market Take
Best guide for a US investor choosing between fund-share exposure to Treasuries and an unsecured certificate obligation with round-the-clock surrender.
Angel Studios vs Legion M
Two fan-funded film studios compared product by product: Angel's NYSE-listed ANGX stock, single-film P&A preferred redeemed at a stated $1.15 and film companies on the Angel Funding portal, against Legion M's company-priced Class A rounds, film participations that paid back 21 percent in 2025 and Film Funds with a 115 percent project limit. Investor fees, dilution, voting control, audit opinions and a sourced repayment table.
Market Take
Best guide for deciding what a fan actually owns when backing a film studio: market-priced listed stock, a company-priced private round, or a claim on one film's receipts.
Augment vs Forge Global
Forge's $100,000 brokered direct secondaries at a stated 2 to 5 percent plus unquantified add-ons, $5,000 Forge Fund SPVs with ADV fee ranges and Forge Price as a disclaimed reference, against Augment's $10,000 units of warehoused series with a transaction fee in gated terms and a 7.33 percent filing ratio.
Market Take
Best guide for choosing between buying the shares themselves through a specialist and buying a low-minimum unit from a platform that is its own seller.
Augment vs Clarity (Formerly Hiive)
Augment Markets' $10,000 inventory-first series units, priced against its own estimate with commissions of 7.33 percent in the Form Ds, against Clarity's $25,000 live order book with up to 4.85 percent buyer and 5.75 percent seller fees, direct transfers and 0-and-0 Hiive Funds.
Market Take
Best guide for choosing between a negotiated price on a visible order book and a lower-minimum unit sold out of platform-owned inventory.
Augment vs EquityZen
Augment Markets' 0-and-0 Collective series, with the 7.33 percent commissions reported in their Form Ds and an affiliated ATS, against EquityZen's 2.5 percent buyer fee, $5,000 minimum and 1,943-SPV record.
Market Take
Best guide for choosing between a stated entry fee on a sourced SPV and a filed commission on platform-owned inventory with a resale venue.
Clarity (formerly Hiive) vs UpMarket
A focused pre-IPO platform comparison of Hiive's live order book and 0% management-fee SPV model against UpMarket's affiliated feeder-fund structure, fee stack, and regulatory disclosures.
Market Take
Best guide for choosing between live-market pre-IPO access and packaged feeder-fund exposure.
AcreTrader vs FarmTogether vs Steward
A side-by-side comparison of farmland equity and agriculture credit platforms, including minimums, accreditation, returns, tax treatment, liquidity, fees, track record transparency, and investor fit.
Market Take
Best guide for choosing between farmland ownership and fixed-rate agriculture lending.
AcreTrader vs Harvest Returns
A focused agriculture comparison of farmland equity versus ag-secured private credit, including returns, tax treatment, liquidity, governance, defaults, and investor fit.
Market Take
Best guide for choosing between direct farmland ownership and collateral-backed agriculture lending.
Masterworks vs Rally
A side-by-side comparison of art investing and fractional collectibles platforms, including access, fees, SEC filing transparency, verified exits, liquidity, tax reporting, and investor fit.
Market Take
Best guide for comparing SEC-filed art shares with fractional collectible series.
Wefunder vs Republic
Cheapest venue or cleanest record: Wefunder's $99.4M of 2024 US Reg CF volume, 0% founder-direct pricing, $283K median verified raise, and resolved $1.4M FINRA fine against Republic's $256.7M verified lifetime book, zero located enforcement actions, Crowd SAFE-dominated instruments, and Reg A lane above $5M.
Market Take
Best guide for founders deciding whether to bring their own crowd nearly fee-free or rent a cleaner-recorded, broader storefront.
StartEngine vs Republic
The only marketplace-versus-marketplace matchup among major US venues: StartEngine's $85.6M of 2024 US Reg CF volume, alumni secondary ATS, resolved $350K portal fine, and 29-194% disclosed Series markups against Republic's $256.7M verified lifetime book, zero located enforcement actions, Crowd SAFE-dominated instruments, and $15.6M of 2024 US volume.
Market Take
Best guide for choosing between the two curated crowdfunding storefronts when fees are a wash and audience, instruments, and records decide it.
DealMaker vs Republic
Curated marketplace versus your own funnel: Republic's $256.7M in verified raises, ~92% funded-book agreement with EDGAR, Crowd SAFE-dominated book, and zero located enforcement actions against DealMaker's Form C-disclosed 8.5% + $4,000/mo schedule, ~$358M of 2025 volume per Kingscrowd, and a marketing arm under attributed journalistic challenge.
Market Take
Best guide for founders choosing between renting a curated storefront audience and owning the raise funnel outright.
DealMaker vs Wefunder
Community round versus raise machine: Wefunder's near-zero founder-direct fees, $283K median closed raise, and resolved $1.4M FINRA fine against DealMaker's Form C-disclosed 8.5% + $4,000/mo schedule, Reg A execution to $75M, and affiliate-paper broker-dealer balance sheet.
Market Take
Best guide for founders weighing the cheapest Reg CF venue against the machine that keeps working above $5M.
DealMaker vs StartEngine
Marketplace versus self-hosted raising: DealMaker's Form C-disclosed 8.5% + $4,000/mo fees and audited broker-dealer record against StartEngine's 2.4M-user shelf, ~7% + 2%-warrant schedule, secondary market, resolved $350K FINRA fine, and 29-194% pre-IPO Series markups.
Market Take
Best guide for founders choosing where to raise — and for investors deciding how much to trust either funnel.
Masterworks vs Willow Wealth (Yieldstreet)
Art equity versus private-market credit: Masterworks' 29 verified exits and quantified fee stack against the platform formerly known as Yieldstreet — its October 2025 rebrand, removed performance history, 2023 SEC order, and pending flagship fund sale.
Market Take
Best guide for understanding that fractional art ownership and art-secured lending are different asset classes.
SongVest vs Royalty Exchange
A music royalty platform comparison across structure, pricing multiples, fees, liquidity, disclosure, and issuer risk.
Market Take
Best guide for choosing between marketplace-priced royalty assets and Reg A+ SongShare securities.
Percent vs Willow Wealth
A private credit and multi-asset alternatives comparison across performance, charge-offs, regulatory history, disclosure, fees, tax reporting, liquidity, and platform stability.
Market Take
Best guide for comparing an active private credit marketplace with the rebranded Yieldstreet / Willow Wealth transition.
Percent vs EquityMultiple
A comparison of Percent's private credit marketplace against EquityMultiple's commercial real estate platform across asset class, disclosure architecture, fees, tax reporting, track record, and liquidity.
Market Take
Best guide for deciding between short-duration private credit notes and commercial real estate debt or equity exposure.
Goldfinch vs Maple
An on-chain private credit comparison of Goldfinch and Maple across credit model, loss-absorption history, scale, structure, regulation, token economics, and liquidity.
Market Take
Best guide for choosing between Maple's active overcollateralized lending book and Goldfinch Prime's accredited Reg D wrapper.
Securitize vs iCapital
A private-markets access comparison of Securitize's self-directed tokenized feeders against iCapital's advisor-only Private Access Funds across access models, feeder fees, minimums, tax, and liquidity.
Market Take
Best guide for choosing between buying a brand-name feeder yourself at $10K-$50K and reaching a 1,630-fund institutional shelf through an advisor at $100K+.
Securitize vs Ondo
A tokenized-RWA comparison of Securitize's NYSE-listed multi-issuer rails (BlackRock BUIDL, VanEck VBILL, Apollo ACRED, Arca ArCoin) against Ondo's single-issuer Treasury products across US eligibility, structure, fees, tax, and tokenized stocks.
Market Take
Best guide for choosing between the widest-access tokenized-RWA marketplace and the cheapest qualified-purchaser Treasury seat — two platforms that are counterparties as much as competitors.
Backed vs Ondo
A tokenized-RWA comparison of Backed and Ondo across US eligibility, instrument structure, backing, tax reporting, pricing mechanics, and token economics.
Market Take
Best guide for comparing tokenized equities and tracker certificates against tokenized Treasury products and Ondo's OUSG structure.
Polymesh vs Centrifuge
A tokenized-RWA infrastructure comparison of Polymesh and Centrifuge across chain architecture, product ownership, token economics, regulatory posture, pricing, and US eligibility.
Market Take
Best guide for separating compliance-native security-token rails from asset-management rails with non-trading tokenized funds.
Burford vs Legalist vs LexShares
A litigation finance comparison across public equity access, institutional fund structures, retail platform lessons, audited returns, carry design, tax reporting, and investor fit.
Market Take
Best guide for comparing public-market litigation finance exposure with institutional and retail litigation-finance fund models.
DiversyFund vs Fundrise
The comparison most pages still get wrong: DiversyFund's $500 non-accredited REIT has been closed since 2024 and never had a redemption plan, while Fundrise still takes $1,000 from anyone. Separates legacy DiversyFund from what it sells today.
Market Take
Best guide for anyone holding DiversyFund shares, or choosing where new non-accredited money should go instead.
GigaStar vs Everbloom
Two platforms sold a share of a YouTube channel's future revenue. GigaStar files a Form C for every drop, reports each creator's revenue in an annual report and runs an SEC-approved ATS. Everbloom sold NFTs in six creators, paid at least one distribution, has no SEC filing on record, and withdrew the retail product with no filing or notice located.
Market Take
Best guide for anyone searching for a YouTube creator investment platform, and a case study in what a retail buyer gives up when a revenue share is sold outside the filing system.
DiversyFund vs Groundfloor
Illiquid equity against loan-linked debt. Groundfloor takes $10 from anyone and the underlying loans ordinarily repay in 6 to 18 months, though the investor's obligation is unsecured and limited recourse; DiversyFund's retail REITs are closed, never had a redemption plan, and stopped distributing in 2021. Neither has a secondary market, but only one has a maturity.
Market Take
Best guide for a DiversyFund holder asking where new money should go when the old position cannot be sold.
DiversyFund vs Arrived
A closed pooled multifamily REIT against $100 fractional shares in individual rental houses. Arrived takes non-accredited money and pays monthly; eight of its nine Regulation A issuers also carry a going-concern qualification, and only the Debt Fund reported positive audited FY2025 net income.
Market Take
Best guide for a non-accredited investor treating Arrived as the DiversyFund replacement, who should read the specific issuer's audit opinion first.
Fundrise vs Arrived
A side-by-side comparison of two retail real estate platforms across fees, minimums, returns, liquidity, tax reporting, audit quality, and investor fit.
Market Take
Best guide for choosing between audited pooled real estate funds and low-minimum property-level access.
Vinovest vs CaskX
Whiskey casks two ways: a managed account at 2.25% to 2.85% a year open to anyone from $1,750, against accredited-only whole barrels at a price that is never itemized, with a 5% exit fee.
Market Take
Best guide for choosing between a fee-based whiskey manager with a documented servicing record and a barrel dealer with a clean record and almost no disclosure.
Destiny Tech100 vs Robinhood Ventures (DXYZ vs RVI)
The two NYSE-listed pre-IPO funds compared from their filings: what $1,000 buys against NAV, total fees, Anthropic, SpaceX and OpenAI exposure, SPVs against direct holdings, and where RVII fits.
Market Take
Best guide for deciding which listed venture fund to buy, and at what premium or discount to its net asset value.
Lofty vs Arrived
Tokenized single-property rentals against fractional Regulation A series: rental income, the full cost of buying and selling, and how reliably each lets you exit.
Market Take
Best guide for choosing between continuous token trading and monthly secondary-market windows, with a worked example of returns after every fee.
Cardone Capital vs Fundrise
Fund against fund: the Cardone Non Accredited Fund against Fundrise's Flagship Real Estate Fund on minimums, the sponsor's profit share, returns, liquidity, Bitcoin and tax forms.
Market Take
Best guide for a small investor weighing a sponsor's 80/20 split with no redemption program against an interval fund's fees and quarterly repurchases.
Dinari vs Backed (dShares vs xStocks)
Tokenized stocks compared from the governing documents: ownership, US access, dividends, fees, redemption, custody and reserves for Dinari's two products and Backed's xStocks.
Market Take
Best guide for telling a token that is backed by a stock from one that records ownership of it.
USVC vs Fundrise VCX
AngelList's USVC against the Fundrise Innovation Fund (NYSE: VCX) on entry price, fee stack, look-through holdings, exit mechanics and tax, from both funds' SEC filings.
Market Take
Best guide for deciding whether to buy a retail venture fund at net asset value or pay the market's premium for one that trades daily on the NYSE.
Fundrise vs Groundfloor
An equity-versus-debt comparison across capital-stack position, fee architecture, redemption mechanics, tax forms, and the concentration hidden inside loan-count diversification.
Market Take
Best guide for deciding between owning pooled real estate equity and lending against individual properties at $10 per loan.
Eagle Point vs Percent
A private credit comparison across capital-stack seniority, liquidity, realized loss experience, distress not shown on deal pages, and what each yield actually pays after return of capital and service fees.
Market Take
Best guide for weighing a liquid, levered CLO equity fund against a hold-to-maturity book of individually underwritten private credit deals.
Moonfare vs iCapital
A private equity access comparison across distribution model, fee transparency, feeder structure, disclosure quality, and scale — one platform you can join, one you can only reach through an adviser.
Market Take
Best guide for understanding whether to access institutional private equity directly or through an advisor-mediated feeder.
Polymarket vs Kalshi
The prediction-market decision from rulebooks and filings: one six-year CFTC stack with a named custody bank and a stable fee formula against a two-venue brand with cheaper US taker fees, an unnamed settlement bank, and an active CFTC probe — with fees, liquidity, legality, taxes, and arbitrage risk compared across all three surfaces.
Market Take
Best guide for choosing a prediction-market venue — and for understanding why 'Polymarket' is two different products.
Compound Real Estate Bonds vs Worthy Bonds
Two $10 demand bonds compared on SEC filings: 8.5% vs 6.5% APY, whether either bond is secured (neither is), how withdrawals work, going-concern audits on every live issuer, and what happened to Worthy's earlier programs.
Market Take
Best guide for pricing an 8.5% demand bond with a clean record against a 6.5% one whose sister programs stopped paying.
SMBX vs Worthy Bonds
Two $10 bonds with no investor fee and different securities underneath: SMBX's are issued by the business itself, amortize monthly and mature; Worthy's are issued by Worthy's own subsidiaries with no maturity and redemption at the issuer's discretion, and three of five programs stopped redeeming, two dissolved with $12.66M unpaid.
Market Take
Best guide for seeing why the issuer and the maturity date matter more than the coupon on a $10 bond, and for reading the one sentence that decides whether you get paid.
MicroVentures vs Wefunder
Two platforms that built the same two-channel machine, a Reg CF book plus a Reg D side-car, and ran it in inverted proportions. Wefunder has filed 2,902 offerings for 2,494 issuers and is still going; MicroVentures filed four in 2025. But 144 of MicroVentures' 195 offerings carry a filed closing amount, 74%, against 11% of Wefunder's.
Market Take
Best guide for seeing why one platform's raise totals can be stated to the dollar and the other's cannot, and for the arithmetic on a flat $10,000 fee against a percentage.
MicroVentures vs StartEngine
The only two platforms in AltStreet's coverage combining broker-dealer operations, Reg CF intermediation, single-company Reg D vehicles and a private-secondary business. StartEngine's 118 vehicles are all 506(c), so it can solicit publicly, and its deal pages disclose an affiliate acquisition cost that computes to a 29% to 194% investor-price premium on the 48 series AltStreet captured. MicroVentures' 870 of 885 are 506(b), which cannot be publicly solicited, and it publishes no price basis at all.
Market Take
Best guide for seeing how one filing choice decides whether you can read a deal before you talk to anyone, and what it means that one platform's economics can be measured and the other's cannot.
MicroVentures vs EquityZen
Two SEC-registered broker-dealers that sell you a membership interest in an LLC holding one private company, not the shares themselves. Compared on 2,942 vehicles enumerated from Form D: EquityZen publishes a 2.5% fee and says it buys from existing shareholders; MicroVentures publishes no vehicle fee and does not say where its shares come from.
Market Take
Best guide for understanding what a pre-IPO SPV actually gives you, why Rule 506(b) means neither platform can advertise these deals publicly, and why the deal-specific structure produces hundreds of vehicles rather than a few large funds.
SMBX vs Honeycomb Credit
Two Reg CF portals lend to the same bakeries and breweries and made opposite choices on everything else: SMBX charges investors nothing and shows every listed bond's repayments but has sold nothing since April 2026; Honeycomb charges 3%, publishes no repayment data, and has 100-plus campaigns open. Issuer filing records computed the same way on both.
Market Take
Best guide for choosing between small business bonds and small business loans, and for seeing what happens to servicing when a Reg CF portal stops originating.
Streitwise vs Fundrise
Fundrise is two regulatory animals: 1940 Act funds for new money, and seven Regulation A eREITs whose redemption plans were suspended and merged away in April 2026. Compared against the Reg A REIT that kept paying.
Market Take
Best guide for understanding what a Regulation A redemption plan is actually worth, judged on how three sponsors behaved in the same month.
Streitwise vs RealtyMogul
Two Regulation A REITs sold shares to retail at $10.00 and both mark near $6.90 at the same date. One still processes redemptions; the other suspended its repurchase program on April 21, 2026.
Market Take
Best guide for seeing why redemption capacity in a non-traded REIT tracks the manager's liquidity and discretion, not portfolio diversification.
Roots vs Fundrise
An independent real estate platform comparison: one Reg A+ sponsor-pipeline REIT with dollar-disclosed economics against a $3.4B complex of 1940 Act registered funds with tested marks and undisclosed affiliate rates.
Market Take
Best guide for weighing independent-governance protection against full-disclosure transparency in non-traded real estate.
tZERO vs North Capital
Two SEC-regulated alternative trading systems for private securities, built on opposite models and compared on the weekly FINRA data neither company publishes. One group distributes and lists its own shelf, and watched its own token become 96% of its volume before it converted away. The other rents out the rails to Arrived, Masterworks, Rally and Ark7, and now trades 26 times the transactions.
Market Take
Best guide for finding out where private securities actually change hands, with the 2025 crossover, the concentration each venue carries from opposite directions, and the custody difference between a carrying broker and an affiliate wallet.
tZERO vs Securitize
The two most-cited regulated tokenization platforms, now suing each other over patents, compared on FINRA's trade data for both ATSs, the audited capital of tZERO's broker-dealers, each product shelf and its wrapper terms, and the directory pages that score them without a single figure.
Market Take
Best guide for separating a transfer agent with BlackRock on it from a license stack still waiting for scale, with the venue volumes neither platform publishes.
Ark7 vs Arrived
The two fractional rental platforms most often compared, compared independently instead of from either platform's blog: a $20 house share financed by a parent with no SEC filings and exited through an order book, against a $100 house share with a visible fee stack, a broker on every offering, nine regional-firm audits and redemption programs on its pooled funds.
Market Take
Best guide for choosing between the cheapest entry in fractional rentals and the more legible structure, with the platform-authored comparisons fact-checked against the filings.
Roots vs Arrived
A fractional real estate comparison built from both platforms' complete audited Reg A filings: one evergreen Atlanta sponsor-pipeline REIT with audited redemption throughput against nine entities of property-level choice carrying going-concern language.
Market Take
Best guide for choosing between a single fund with a working exit door and pick-your-property exposure across markets.
Groundfloor vs Arrived
Two Regulation A Tier 2 platforms at the same regulatory tier, compared on audit outcomes, fee architecture, capital-stack position, duration, and exit mechanics.
Market Take
Best guide for choosing between lending on residential renovation projects and owning fractional rental equity at retail minimums.
Arrived vs Concreit
A Regulation A fractional real estate comparison across governance, audited financials, fee architecture, tax treatment, liquidity, and disclosure quality.
Market Take
Best guide for comparing Arrived's property-level and debt-fund model with Concreit's Fund I and Series LLC structure.
Concreit vs RealtyMogul
A Regulation A real estate platform comparison across current operating state, audited financials, redemption mechanics, tax reporting, governance, and disclosure quality.
Market Take
Best guide for comparing Concreit's active low-minimum Reg A vehicles with RealtyMogul's paused REITs and Wideman-era marketplace.
Fundrise vs CrowdStreet
A real estate platform comparison across current product availability, audit quality, track record interpretation, fees, liquidity, tax reporting, and investor fit.
Market Take
Best guide for comparing Fundrise's operating 40 Act funds with CrowdStreet's post-marketplace institutional fund model.
CrowdStreet vs Willow Wealth
A private markets platform comparison across restructuring, transparency, historical performance disclosure, regulatory record, product availability, and investor fit.
Market Take
Best guide for comparing two restructured retail private markets platforms and their disclosure responses after major losses.
Arrived vs RealtyMogul
A side-by-side comparison of fractional real estate platforms across availability, audit quality, redemption status, fees, yield, and investor fit.
Market Take
Best guide for comparing currently available Arrived products with RealtyMogul's paused REITs and Wideman-era constraints.
Arrived vs EquityMultiple
A side-by-side comparison of residential fractional real estate and accredited-only commercial real estate across access, fees, returns, audit quality, tax reporting, and investor fit.
Market Take
Best guide for choosing between low-minimum retail real estate access and accredited-only commercial CRE exposure.
Income Investing
How to Invest in Royalty Income
A decision guide to buying royalty income: music and media royalties at auction or as Reg A SongShares, oil and gas royalty and mineral interests, royalty trusts and mineral funds, with marketplace multiples, decay data, fees, taxes and risks.
Market Take
Best guide for understanding what royalties actually sell for and how fast the income decays before buying any of them.
How to Invest in Mineral Rights
A decision guide to mineral rights investing: mineral, royalty, overriding royalty and working interests explained, then the four access routes (listed royalty trusts, Efficient Markets auctions, direct purchases, private funds and Reg D offerings) with costs, yields, per-acre valuation, due diligence, depletion and K-1 versus 1099 tax treatment, basin differences and the pros and cons.
Market Take
Best guide for knowing which oil and gas interest a listing actually sells and what an acre is worth by development status before buying through any route.
Archive
Archived Guides
Preserved for methodology, historical context, and platform mechanics after the primary event has passed.
Institutional Briefing
Receive institutional-grade analysis before the broader market catches up.
Weekly AltStreet briefing for sophisticated investors tracking private markets, platform structure, fee drag, tax timing, and implementation risk. The goal is simple: give you the decision logic, not just another headline.
Get the briefing
Weekly alternative-investment research, platform intelligence, and structural comparison updates.
Independent intelligence from AltStreet. No hype. No sponsor spin.
Research Standard
Research that helps investors make better alternative asset decisions.
Alternative investments often look simpler than they are. Platform access, transfer mechanics, tax treatment, liquidity constraints, and layered fees can materially change the outcome even when the underlying asset is the same.
AltStreet guides are designed to surface those realities early, so readers can compare pathways with more discipline and less reliance on platform marketing or fragmented information.